220 related articles for article (PubMed ID: 33038765)
1. Silencing KIF18B enhances radiosensitivity: identification of a promising therapeutic target in sarcoma.
Liu W; Yu Z; Tang H; Wang X; Zhang B; Zhao J; Liu X; Zhang J; Wei M
EBioMedicine; 2020 Nov; 61():103056. PubMed ID: 33038765
[TBL] [Abstract][Full Text] [Related]
2. Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.
Tang Z; Zeng Q; Li Y; Zhang X; Ma J; Suto MJ; Xu B; Yi N
Oncotarget; 2017 Apr; 8(16):27428-27439. PubMed ID: 28404969
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma.
Liu Q; Zhang X; Tang H; Liu J; Fu C; Sun M; Zhao L; Wei M; Yu Z; Wang P
Pathol Oncol Res; 2020 Jul; 26(3):1583-1594. PubMed ID: 31489573
[TBL] [Abstract][Full Text] [Related]
4. Kinesin Family Member B18 Is Related to Gastric Mucin Phenotype and Contributes to Gastric Cancer Progression by Regulating Epithelial-Mesenchymal Transition.
Ishikawa A; Yasumatsu R; Fukui T; Kido A; Katsuya N; Sentani K; Kuraoka K; Oue N; Suzuki T; Oka S; Kotachi T; Tanabe K; Ohdan H; Ashktorab H; Smoot D; Yasui W
Oncology; 2024; 102(4):354-365. PubMed ID: 37812924
[TBL] [Abstract][Full Text] [Related]
5. Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.
Tang Z; Zeng Q; Li Y; Zhang X; Suto MJ; Xu B; Yi N
Oncol Rep; 2017 Nov; 38(5):2814-2824. PubMed ID: 29048650
[TBL] [Abstract][Full Text] [Related]
6. Silencing of KIF18B restricts proliferation and invasion and enhances the chemosensitivity of breast cancer via modulating Akt/GSK-3β/β-catenin pathway.
Jiang J; Liu T; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Biofactors; 2021 Sep; 47(5):754-767. PubMed ID: 34058791
[TBL] [Abstract][Full Text] [Related]
7. Kinesin family member 18B: A contributor and facilitator in the proliferation and metastasis of cutaneous melanoma.
Yan H; Zhu C; Zhang L
J Biochem Mol Toxicol; 2019 Dec; 33(12):e22409. PubMed ID: 31617652
[TBL] [Abstract][Full Text] [Related]
8. KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma.
Qiu MJ; Zhang L; Chen YB; Zhu LS; Zhang B; Li QT; Yang SL; Xiong ZF
Int J Biochem Cell Biol; 2021 Aug; 137():106037. PubMed ID: 34217812
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression.
Omori T; Tazawa H; Yamakawa Y; Osaki S; Hasei J; Sugiu K; Komatsubara T; Fujiwara T; Yoshida A; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
PLoS One; 2021; 16(4):e0250643. PubMed ID: 33886686
[TBL] [Abstract][Full Text] [Related]
10. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
[TBL] [Abstract][Full Text] [Related]
11. HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas.
Ernst A; Anders H; Kapfhammer H; Orth M; Hennel R; Seidl K; Winssinger N; Belka C; Unkel S; Lauber K
Cancer Lett; 2015 Sep; 365(2):211-22. PubMed ID: 26044951
[TBL] [Abstract][Full Text] [Related]
12. Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis.
Itzel T; Scholz P; Maass T; Krupp M; Marquardt JU; Strand S; Becker D; Staib F; Binder H; Roessler S; Wang XW; Thorgeirsson S; Müller M; Galle PR; Teufel A
Bioinformatics; 2015 Jan; 31(2):216-24. PubMed ID: 25236463
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma.
Tang S; Wu Z; Chen L; She L; Zuo W; Luo W; Zhang Y; Liang S; Liu G; He B; He J; Zhang N
Front Immunol; 2023; 14():1258344. PubMed ID: 37744335
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance And Integrative Analysis Of Kinesin Family Member 18B In Lung Adenocarcinoma.
Zhong Y; Jiang L; Long X; Zhou Y; Deng S; Lin H; Li X
Onco Targets Ther; 2019; 12():9249-9264. PubMed ID: 31807007
[TBL] [Abstract][Full Text] [Related]
15. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse.
Seifert M; Peitzsch C; Gorodetska I; Börner C; Klink B; Dubrovska A
PLoS Comput Biol; 2019 Nov; 15(11):e1007460. PubMed ID: 31682594
[TBL] [Abstract][Full Text] [Related]
16. A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway.
Meng J; Li P; Zhang Q; Yang Z; Fu S
Oncotarget; 2014 Jul; 5(13):4683-93. PubMed ID: 24970813
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Shen R; Liu B; Li X; Yu T; Xu K; Ma J
BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
[TBL] [Abstract][Full Text] [Related]
18. Silencing the expression of MTDH increases the radiation sensitivity of SKOV3 ovarian cancer cells and reduces their proliferation and metastasis.
Chen J; Jia Y; Jia ZH; Zhu Y; Jin YM
Int J Oncol; 2018 Nov; 53(5):2180-2190. PubMed ID: 30226587
[TBL] [Abstract][Full Text] [Related]
19. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
Wei T; Cheng S; Fu XN; Feng LJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4.
Ha Thi HT; Kim HY; Kim YM; Hong S
Neoplasia; 2019 Sep; 21(9):882-892. PubMed ID: 31387015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]